Drugs for hypertension
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Drugs for Hypertension: A Comprehensive Overview
Introduction to Hypertension and Its Treatment
Hypertension, or high blood pressure, is a significant risk factor for cardiovascular diseases, including stroke, myocardial infarction, heart failure, and renal failure. Effective management of hypertension is crucial to reduce these risks. Various classes of antihypertensive drugs are available, each with distinct mechanisms of action and efficacy profiles.
First-Line Antihypertensive Drugs
Thiazide Diuretics
Thiazide diuretics, particularly low-dose thiazides, are often recommended as the first-line treatment for hypertension. High-quality evidence indicates that low-dose thiazides reduce mortality, total cardiovascular events (CVS), stroke, and coronary heart disease (CHD) . However, high-dose thiazides, while effective in reducing stroke and total CVS, do not significantly impact mortality or CHD .
ACE Inhibitors
Angiotensin-converting enzyme (ACE) inhibitors are another effective first-line treatment. They have been shown to reduce mortality, stroke, CHD, and total CVS . Despite their efficacy, the evidence supporting ACE inhibitors is considered to be of lower quality compared to thiazides .
Calcium Channel Blockers
Calcium channel blockers are also used as first-line agents. They reduce stroke and total CVS but do not significantly impact mortality or CHD . The evidence for their effectiveness is of low quality .
Beta-Blockers
Beta-blockers are less effective compared to thiazides and ACE inhibitors. They reduce stroke and total CVS but do not significantly affect mortality or CHD . Additionally, beta-blockers are associated with a higher rate of withdrawals due to adverse effects .
Other Drug Classes
There is limited evidence for the efficacy of angiotensin II receptor blockers (ARBs) and alpha-blockers as first-line treatments due to a lack of randomized controlled trials (RCTs) .
Dual Combination Therapy
Dual combination therapy, involving two antihypertensive drugs at low-to-standard doses, has been shown to be more effective than monotherapy in reducing systolic blood pressure (SBP) and improving blood pressure control without significantly increasing adverse events. This approach may offer a more balanced efficacy and tolerability profile for initial hypertension treatment.
Special Considerations for Different Age Groups
Adults Aged 18 to 59 Years
In adults aged 18 to 59 years with mild to moderate hypertension, antihypertensive drugs have a small absolute effect in reducing cardiovascular mortality and morbidity, primarily due to a reduction in cerebrovascular events. However, there is no significant reduction in all-cause mortality or CHD.
Adults Aged 60 Years or Older
For adults aged 60 years or older, antihypertensive treatment significantly reduces all-cause mortality, cardiovascular morbidity and mortality, cerebrovascular events, and CHD. Most evidence supports the use of thiazide diuretics as the first-line treatment in this age group.
Conclusion
Thiazide diuretics, particularly low-dose thiazides, are the most effective first-line treatment for hypertension, reducing mortality and various cardiovascular events. ACE inhibitors and calcium channel blockers are also effective but with lower quality evidence. Beta-blockers are less effective and associated with higher adverse effects. Dual combination therapy offers a promising alternative to monotherapy, providing better blood pressure control with minimal increase in adverse events. Treatment strategies should be tailored to the patient's age and comorbidities to optimize outcomes.
Sources and full results
Most relevant research papers on this topic